المؤلفون: Bristol-Myers Squibb, The Cleveland Clinic, Medical College of Wisconsin, National Institutes of Health (NIH), National Cancer Institute (NCI)

المساهمون: Nabil F. Saba, Principal Investigator

المصدر: Phase II Study of IMRT Re-Irradiation With Concurrent/Adjuvant Nivolumab in Patients With Locoregionally Recurrent or Second Primary Squamous Cell Cancer of the Head and Neck

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03521570Test

المؤلفون: Exelixis, National Institutes of Health (NIH), National Cancer Institute (NCI)

المساهمون: Nabil F. Saba, Principal Investigator

المصدر: A Phase II Trial of Pembrolizumab and Cabozantinib in Patients With RM SCCHN

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03468218Test

المساهمون: Nabil F. Saba, Associate Professor

المصدر: Phase II Study of Pre-Operative Chemotherapy With Taxol, Cisplatin, and 5-Fluorouracil Followed by G-CSF in Patients With Resectable Local-Regional Carcinoma of Esophagus

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00208936Test

المؤلفون: Sanofi

المساهمون: Nabil F. Saba, Professor

المصدر: Saba NF, Magliocca KR, Kim S, Muller S, Chen Z, Owonikoko TK, Sarlis NJ, Eggers C, Phelan V, Grist WJ, Chen AY, Ramalingam SS, Chen ZG, Beitler JJ, Shin DM, Khuri FR, Marcus AI. Acetylated tubulin (AT) as a prognostic marker in squamous cell carcinoma of the head and neck. Head Neck Pathol. 2014 Mar;8(1):66-72. doi: 10.1007/s12105-013-0476-6. Epub 2013 Jul 24.
Phase II Study of Induction Docetaxel, Cisplatin and 5-Fluorouracil Chemotherapy in Squamous Cell Carcinoma of the Oral Cavity With Molecular Endpoints

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00400205Test

المؤلفون: Genentech, Inc.

المساهمون: Nabil F. Saba, Principal Investigator

المصدر: Phase II Study of Cetuximab and Bevacizumab in Esophageal Carcinoma That Failed First Line Therapy

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00636298Test

المؤلفون: Novartis

المساهمون: Nabil F. Saba, Physician

المصدر: Saba NF, Hurwitz SJ, Magliocca K, Kim S, Owonikoko TK, Harvey D, Ramalingam SS, Chen Z, Rogerio J, Mendel J, Kono SA, Lewis C, Chen AY, Higgins K, El-Deiry M, Wadsworth T, Beitler JJ, Shin DM, Sun SY, Khuri FR. Phase 1 and pharmacokinetic study of everolimus in combination with cetuximab and carboplatin for recurrent/metastatic squamous cell carcinoma of the head and neck. Cancer. 2014 Dec 15;120(24):3940-51. doi: 10.1002/cncr.28965. Epub 2014 Aug 7.
A Phase I/IIB Study of Combination Weekly Carboplatin, Cetuximab and Dose Escalation of RAD001 in Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT01283334Test

المؤلفون: Novartis

المساهمون: Nabil F. Saba, Principal Investigator

المصدر: Phase I/IIB Study of Induction Chemotherapy With XELOX, Followed by Radiation Therapy and Dose Escalation of RAD001 in Patients With Esophageal Cancer

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT01490749Test

المؤلفون: Synta Pharmaceuticals Corp.

المساهمون: Nabil F. Saba, Principal Investigator

المصدر: A Molecularly Driven Pilot Study of Preoperative Ganetespib in Resectable Squamous Cell Carcinoma of the Head and Neck (SCCHN)

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT02334319Test